日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Collateral hypersensitivity between ZY19489 and piperaquine neutralizes PfCRT-mediated drug efflux and Plasmodium falciparum resistance

ZY19489 与哌喹之间的协同超敏反应可中和 PfCRT 介导的药物外排和恶性疟原虫耐药性。

Okombo, John; Ndiaye, Tolla; Qahash, Tarrick; Moura, Igor M R; Gil-Iturbe, Eva; Hagenah, Laura M; Bridgford, Jessica L; Bonatto, Vinicius; Ward, Kurt E; Yeo, Tomas; Narwal, Sunil K; Orta, Lily V; Anderson, Isla; Dhingra, Satish K; Pasaje, Charisse Flerida A; Park, Heekuk; Kim, Jonathan; Guido, Rafael V C; Angulo-Barturen, Iñigo; Niles, Jacquin C; Mancia, Filippo; Uhlemann, Anne-Catrin; Mok, Sachel; Quick, Matthias; Winzeler, Elizabeth A; Leroy, Didier; Llinás, Manuel; Thathy, Vandana; Fidock, David A

Identification of potent and reversible piperidine carboxamides that are species-selective orally active proteasome inhibitors to treat malaria.

鉴定出强效且可逆的哌啶甲酰胺类化合物,它们是具有物种选择性的口服活性蛋白酶体抑制剂,可用于治疗疟疾

Lawong Aloysus, Gahalawat Suraksha, Ray Sneha, Ho Nhi, Han Yan, Ward Kurt E, Deng Xiaoyi, Chen Zhe, Kumar Ashwani, Xing Chao, Hosangadi Varun, Fairhurst Kate J, Tashiro Kyuto, Liszczak Glen, Shackleford David M, Katneni Kasiram, Chen Gong, Saunders Jessica, Crighton Elly, Casas Arturo, Robinson Joshua J, Imlay Leah S, Zhang Xiaoyu, Lemoff Andrew, Zhao Zhiyu, Angulo-Barturen Iñigo, Jiménez-Díaz María Belén, Wittlin Sergio, Campbell Simon F, Fidock David A, Laleu Benoît, Charman Susan A, Ready Joseph M, Phillips Margaret A

Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea

厄立特里亚青蒿素耐药性HRP2阴性疟疾患病率不断上升

Mihreteab, Selam; Platon, Lucien; Berhane, Araia; Stokes, Barbara H; Warsame, Marian; Campagne, Pascal; Criscuolo, Alexis; Ma, Laurence; Petiot, Nathalie; Doderer-Lang, Cécile; Legrand, Eric; Ward, Kurt E; Zehaie Kassahun, Assefash; Ringwald, Pascal; Fidock, David A; Ménard, Didier

Mapping the genomic landscape of multidrug resistance in Plasmodium falciparum and its impact on parasite fitness.

绘制恶性疟原虫多重耐药性的基因组图谱及其对寄生虫适应性的影响

Mok Sachel, Yeo Tomas, Hong Davin, Shears Melanie J, Ross Leila S, Ward Kurt E, Dhingra Satish K, Kanai Mariko, Bridgford Jessica L, Tripathi Abhai K, Mlambo Godfree, Burkhard Anna Y, Fairhurst Kate J, Gil-Iturbe Eva, Park Heekuk, Rozenberg Felix D, Kim Jonathan, Mancia Filippo, Quick Matthias, Uhlemann Anne-Catrin, Sinnis Photini, Fidock David A

Plasmodium falciparum resistance to artemisinin-based combination therapies

恶性疟原虫对青蒿素类联合疗法的耐药性

Ward, Kurt E; Fidock, David A; Bridgford, Jessica L

Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasome

设计对恶性疟原虫具有体内口服疗效且对人蛋白酶体具有选择性的蛋白酶体抑制剂

Xie, Stanley C; Metcalfe, Riley D; Mizutani, Hirotake; Puhalovich, Tanya; Hanssen, Eric; Morton, Craig J; Du, Yawei; Dogovski, Con; Huang, Shih-Chung; Ciavarri, Jeffrey; Hales, Paul; Griffin, Robert J; Cohen, Lawrence H; Chuang, Bei-Ching; Wittlin, Sergio; Deni, Ioanna; Yeo, Tomas; Ward, Kurt E; Barry, Daniel C; Liu, Boyin; Gillett, David L; Crespo-Fernandez, Benigno F; Ottilie, Sabine; Mittal, Nimisha; Churchyard, Alisje; Ferguson, Daniel; Aguiar, Anna Caroline C; Guido, Rafael V C; Baum, Jake; Hanson, Kirsten K; Winzeler, Elizabeth A; Gamo, Francisco-Javier; Fidock, David A; Baud, Delphine; Parker, Michael W; Brand, Stephen; Dick, Lawrence R; Griffin, Michael D W; Gould, Alexandra E; Tilley, Leann